FAIRFAX, Va., Dec. 4, 2017 /PRNewswire/ -- The Centers for
Disease Control and Prevention (CDC) National Center for Chronic
Disease Prevention and Health Promotion has selected ICF
(NASDAQ:ICFI), a global consulting and digital services provider,
for a re-compete task order to continue its role in maintaining the
National Program of Cancer Registries – Cancer Surveillance System
(NPCR-CSS), one of the agency's largest disease surveillance
systems.
The task order, which was awarded in the third quarter, has a
value of over $9 million and a term
of four years including one base and three option years.
"Population-based cancer surveillance is playing an increasing
role in informing cancer prevention and control interventions,"
said David Cotton, senior vice
president for ICF. "ICF is proud to serve as a trusted partner in
helping CDC collect, aggregate and make sense of cancer data and of
our involvement in a program that ultimately contributes to
reducing the cancer burden in the U.S. population."
ICF has helped CDC maintain the national cancer surveillance
system since it was established in 2000. During this time, ICF has
completed 18 consecutive national data submissions, collecting,
processing and disseminating data on cancer occurrence, treatment
and outcomes from now 49 state and territorial cancer registries
across the United States.
Data collected under the NPCR-CSS today represents 97 percent of
the U.S. population. When combined with the National Cancer
Institute's Surveillance, Epidemiology, and End Results (SEER)
program data, the entire U.S. population is represented. Both
NPCR-CSS and SEER data are reported in the U.S. Cancer Statistics
Incidence and Mortality Web-based Report, CDC's official federal
statistics on cancer incidence. This information enables
researchers, clinicians, policy-makers, public health professionals
and the public to monitor the burden of cancer, evaluate the
successes of programs and identify additional needs for cancer
prevention and control efforts at national, state and local
levels.
Through this and other major disease surveillance work, ICF has
assembled a seasoned team of experts with extensive experience in
cancer and health data management, processing and quality
validation; registry operations; and surveillance system design and
architecture. These experts have cultivated long-standing working
relationships with the individual state cancer registries and
surveillance community at large. And they have the agility to
accommodate the ever-changing data and security requirements and
rapidly evolving technologies involved in this work.
Read more about ICF's disease surveillance, health informatics
and data management and dissemination services.
About ICF
ICF is a global consulting services
company with over 5,000 specialized experts, but we are not your
typical consultants. At ICF, business analysts and policy
specialists work together with digital strategists, data scientists
and creatives. We combine unmatched industry expertise with
cutting-edge engagement capabilities to help organizations solve
their most complex challenges. Since 1969, public and private
sector clients have worked with ICF to navigate change and shape
the future. Learn more at icf.com.
Caution Concerning Forward-looking Statements
Statements that are not historical facts and involve known and
unknown risks and uncertainties are "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995.
Such statements may concern our current expectations about Cour
future results, plans, operations and prospects and involve certain
risks, including those related to the government contracting
industry generally; our particular business, including our
dependence on contracts with U.S. federal government agencies; and
our ability to acquire and successfully integrate businesses. These
and other factors that could cause our actual results to differ
from those indicated in forward-looking statements are included in
the "Risk Factors" section of our securities filings with the
Securities and Exchange Commission. The forward-looking statements
included herein are only made as of the date hereof, and we
specifically disclaim any obligation to update these statements in
the future.
Contact: Lauren Dyke,
lauren.dyke@ICF.com, +1.571.373.5577
View original content with
multimedia:http://www.prnewswire.com/news-releases/cdc-awards-icf-9-million-cancer-surveillance-task-order-300565435.html
SOURCE ICF International